Christopher K Rayner (Chinmay S Marathe)
ORCIDPublication Activity (10 Years)
Years Active: 2018-2022
Publications (10 Years): 7
Publications (10 Years): 7
Publications
- Christopher K Rayner, Karen Louise Jones, Christopher K Rayner, Chinmay S Marathe, Michael HorowitzComment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509-2518. Diabetes care 44 (11) (2022)
- Ryan Joseph Jalleh, Tongzhi Wu, Karen Louise Jones, Christopher K Rayner, Michael Horowitz, Christopher K Rayner
- Tejaswini Arunachala Murthy, Lee-Anne S Chapple, Kylie M Lange, Christopher K Rayner, Michael Horowitz, Sandra L Peake, Marianne J ChapmanGastrointestinal dysfunction during enteral nutrition delivery in intensive care unit (ICU) patients: Risk factors, natural history, and clinical implications. A post-hoc analysis of The Augmented versus Routine approach to Giving Energy Trial (TARGET). The American journal of clinical nutrition 116 (2) (2022)
- Michael Horowitz, Christopher K Rayner, Christopher K Rayner, Chinmay S Marathe, Mahesh Michael Umapathysivam, Karen Louise Jones
- Michael Horowitz, Christopher K Rayner, Christopher K Rayner, Chinmay S Marathe, Karen Louise Jones
- Michael Horowitz, Christopher K Rayner, Christopher K Rayner, Chinmay S Marathe, Karen Louise Jones
- Christopher K Rayner, Jessica A Marathe, Christopher K Rayner, Palash Kar, Karen Louise Jones, Michael Horowitz